MicroRNAsMicroRNAs (miRNA) have been implicated in the epigenetic regu การแปล - MicroRNAsMicroRNAs (miRNA) have been implicated in the epigenetic regu อังกฤษ วิธีการพูด

MicroRNAsMicroRNAs (miRNA) have bee

MicroRNAs

MicroRNAs (miRNA) have been implicated in the epigenetic regulation of cancer cells and the following miRNAs have been identified in tumor-related functions in osteosarcoma. Hypoxia-inducible factor-2α (HIF-2α) promoter upstream transcript (HIF2PUT) is a novel long non-coding RNA (lncRNA); overexpression of HIF2PUT markedly decreased the percentage of CD133-expressing cells and impaired OSC sphere-forming capacity in MG63 osteosarcoma cells [49]. Silencing miR-133a reduced cell invasion and prolonged survival in osteosarcoma-bearing mice, suggesting that miR-133a may play a role in OSC regulation [50]. A total of 189 miRNAs were reported to be differentially expressed in 3AB-OS CSCs relative to their parental cells. These included two miRNA families, let-7/98 and miR-29a, b, c, and their anticorrelated mRNAs (MSTN, CCND2, Lin28B, MEST, HMGA2 and GHR), suggesting they may comprise a set of OSC markers [51]. MiR-29b-1 was found to negatively regulate expressions of CD133, N-Myc, Oct3/4, Sox2 and Nanog in OSCs; in contrast overexpression of miR-29b-1 consistently reduced growth and the sphere-forming ability of OSCs in this cell line [52].

Telomerase and DNA repair

Telomerase activity has been detected in most malignant cancer cells, including osteosarcoma, and is crucial for the maintenance of stem/progenitor cells. However the relationship between telomerase expression and CSCs remains unclear [71]. High telomerase activity has been linked to enhanced stem cell-like properties in osteosarcoma cells, including sphere-forming capacity, invasiveness, metastatic potential and resistance to chemotherapeutic agents [53]. In addition, sphere-driving OSCs displayed increased expressions of CD117 and Stro-1 compared to telomerase-negative cells; conversely inhibition of telomerase resulted in decreased tumorigenic potential in osteosarcoma [53]. Increased expression of DNA repair enzyme genes, MLH1 and MSH2, has also been linked to chemoresistance in osteosarcoma sphere cells [13].
0/5000
จาก: -
เป็น: -
ผลลัพธ์ (อังกฤษ) 1: [สำเนา]
คัดลอก!
MicroRNAsMicroRNAs (miRNA) have been implicated in the epigenetic regulation of cancer cells and the following miRNAs have been identified in tumor-related functions in osteosarcoma. Hypoxia-inducible factor-2α (HIF-2α) promoter upstream transcript (HIF2PUT) is a novel long non-coding RNA (lncRNA); overexpression of HIF2PUT markedly decreased the percentage of CD133-expressing cells and impaired OSC sphere-forming capacity in MG63 osteosarcoma cells [49]. Silencing miR-133a reduced cell invasion and prolonged survival in osteosarcoma-bearing mice, suggesting that miR-133a may play a role in OSC regulation [50]. A total of 189 miRNAs were reported to be differentially expressed in 3AB-OS CSCs relative to their parental cells. These included two miRNA families, let-7/98 and miR-29a, b, c, and their anticorrelated mRNAs (MSTN, CCND2, Lin28B, MEST, HMGA2 and GHR), suggesting they may comprise a set of OSC markers [51]. MiR-29b-1 was found to negatively regulate expressions of CD133, N-Myc, Oct3/4, Sox2 and Nanog in OSCs; in contrast overexpression of miR-29b-1 consistently reduced growth and the sphere-forming ability of OSCs in this cell line [52].Telomerase and DNA repairTelomerase activity has been detected in most malignant cancer cells, including osteosarcoma, and is crucial for the maintenance of stem/progenitor cells. However the relationship between telomerase expression and CSCs remains unclear [71]. High telomerase activity has been linked to enhanced stem cell-like properties in osteosarcoma cells, including sphere-forming capacity, invasiveness, metastatic potential and resistance to chemotherapeutic agents [53]. In addition, sphere-driving OSCs displayed increased expressions of CD117 and Stro-1 compared to telomerase-negative cells; conversely inhibition of telomerase resulted in decreased tumorigenic potential in osteosarcoma [53]. Increased expression of DNA repair enzyme genes, MLH1 and MSH2, has also been linked to chemoresistance in osteosarcoma sphere cells [13].
การแปล กรุณารอสักครู่..
ผลลัพธ์ (อังกฤษ) 2:[สำเนา]
คัดลอก!
MicroRNAs microRNAs (miRNA) have been implicated in the epigenetic Regulation of Cancer cells have been identified and the following miRNAs in tumor-related functions in osteosarcoma. Hypoxia-inducible factor-2α (HIF-2α) promoter upstream transcript (HIF2PUT) is a novel long non-coding RNA (lncRNA); overexpression of HIF2PUT markedly decreased the percentage of CD133-expressing cells and impaired OSC sphere-forming capacity in MG63 osteosarcoma cells [49]. Silencing miR-133a reduced cell invasion and prolonged survival in osteosarcoma-bearing mice, suggesting that miR-133a may play a role in OSC regulation [50]. A total of 189 miRNAs were reported to be differentially expressed in 3AB-OS CSCs relative to their parental cells. These included two miRNA families, let-7/98 and miR-29a, b, c, and their anticorrelated mRNAs (MSTN, CCND2, Lin28B, MEST, HMGA2 and GHR), suggesting they may comprise a set of OSC markers [51]. . MiR-29b-1 was found to negatively regulate expressions of CD133, N-Myc, Oct3 / 4, Sox2 and Nanog in OSCs; in contrast overexpression of miR-29b-1 consistently reduced growth and the Sphere-Forming ability of OSCs in this Cell line [52]. Telomerase and DNA Repair Telomerase Activity has been detected in Most malignant Cancer cells, including osteosarcoma, and is CRUCIAL for. the maintenance of stem / progenitor cells. However the relationship between telomerase expression and CSCs remains unclear [71]. High telomerase activity has been linked to enhanced stem cell-like properties in osteosarcoma cells, including sphere-forming capacity, invasiveness, metastatic potential and resistance to chemotherapeutic agents [53]. In addition, sphere-driving OSCs displayed increased expressions of CD117 and Stro-1 compared to telomerase-negative cells; conversely inhibition of telomerase resulted in decreased tumorigenic potential in osteosarcoma [53]. Increased expression of DNA repair enzyme genes, MLH1 and MSH2, has also been linked to chemoresistance in osteosarcoma sphere cells [13].






การแปล กรุณารอสักครู่..
ผลลัพธ์ (อังกฤษ) 3:[สำเนา]
คัดลอก!
MicroRNAs

MicroRNAs (miRNA) have been implicated in the epigenetic regulation of cancer cells and the following miRNAs. Have been identified in tumor-related functions in osteosarcoma. Hypoxia-inducible factor-2 α (HIF-2 α) promoter upstream. Transcript (HIF2PUT) is a novel long non-coding RNA (lncRNA);Overexpression of HIF2PUT markedly decreased the percentage of CD133-expressing cells and impaired OSC sphere-forming capacity. In MG63 osteosarcoma cells [49]. Silencing miR-133a reduced cell invasion and prolonged survival in osteosarcoma-bearing. Mice suggesting that, miR-133a may play a role in OSC 50 regulation [].
การแปล กรุณารอสักครู่..
 
ภาษาอื่น ๆ
การสนับสนุนเครื่องมือแปลภาษา: กรีก, กันนาดา, กาลิเชียน, คลิงออน, คอร์สิกา, คาซัค, คาตาลัน, คินยารวันดา, คีร์กิซ, คุชราต, จอร์เจีย, จีน, จีนดั้งเดิม, ชวา, ชิเชวา, ซามัว, ซีบัวโน, ซุนดา, ซูลู, ญี่ปุ่น, ดัตช์, ตรวจหาภาษา, ตุรกี, ทมิฬ, ทาจิก, ทาทาร์, นอร์เวย์, บอสเนีย, บัลแกเรีย, บาสก์, ปัญจาป, ฝรั่งเศส, พาชตู, ฟริเชียน, ฟินแลนด์, ฟิลิปปินส์, ภาษาอินโดนีเซี, มองโกเลีย, มัลทีส, มาซีโดเนีย, มาราฐี, มาลากาซี, มาลายาลัม, มาเลย์, ม้ง, ยิดดิช, ยูเครน, รัสเซีย, ละติน, ลักเซมเบิร์ก, ลัตเวีย, ลาว, ลิทัวเนีย, สวาฮิลี, สวีเดน, สิงหล, สินธี, สเปน, สโลวัก, สโลวีเนีย, อังกฤษ, อัมฮาริก, อาร์เซอร์ไบจัน, อาร์เมเนีย, อาหรับ, อิกโบ, อิตาลี, อุยกูร์, อุสเบกิสถาน, อูรดู, ฮังการี, ฮัวซา, ฮาวาย, ฮินดี, ฮีบรู, เกลิกสกอต, เกาหลี, เขมร, เคิร์ด, เช็ก, เซอร์เบียน, เซโซโท, เดนมาร์ก, เตลูกู, เติร์กเมน, เนปาล, เบงกอล, เบลารุส, เปอร์เซีย, เมารี, เมียนมา (พม่า), เยอรมัน, เวลส์, เวียดนาม, เอสเปอแรนโต, เอสโทเนีย, เฮติครีโอล, แอฟริกา, แอลเบเนีย, โคซา, โครเอเชีย, โชนา, โซมาลี, โปรตุเกส, โปแลนด์, โยรูบา, โรมาเนีย, โอเดีย (โอริยา), ไทย, ไอซ์แลนด์, ไอร์แลนด์, การแปลภาษา.

Copyright ©2024 I Love Translation. All reserved.

E-mail: